Evidence map›Paper›PMID 35271639›Full record

ArticlePloS one2022

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors.

Alexander G J Skorput, Reshma Gore, Rachel Schorn, Maureen S Riedl, Ezequiel Marron Fernandez de Velasco, Bailey Hadlich, Kelley F Kitto, Carolyn A Fairbanks, Lucy Vulchanova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. AAV-mediated gene transfer to colon-innervating primary afferent neurons.Frontiers in pain research (Lausanne, Switzerland) · 2023
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alexander G J SkorputDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Reshma GoreDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-2889-7775
Rachel SchornDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Maureen S RiedlDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Ezequiel Marron Fernandez de VelascoDepartment of Pharmacology, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Bailey HadlichDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Kelley F KittoDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Carolyn A FairbanksDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.
Lucy VulchanovaDepartment of Neuroscience, Medical School, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-6577-4467
University of Minnesota Medical Center · USUniversity of Minnesota · US

Funding

NEUROSCIENCE TRAINING IN DRUG ABUSE RESEARCHT32DA007234 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Paul G Mermelstein, Jocelyn M Richard · 1986 to 2026
$10.9M
Structural, single-cell transcriptomic, and functional 3-photon mapping of spinal pain circuitsR34NS111654 · NINDS · UNIVERSITY OF MINNESOTA · PI KARA, PRAKASH, KODANDARAMAIAH, SUHASA B · 2019 to 2019
$660k
Selective peripheral neuromodulation through organ-specific AAV-mediated gene transferU18EB021716 · NIBIB · UNIVERSITY OF MINNESOTA · PI VULCHANOVA, LYUDMILA H · 2015 to 2016
$456k
NIBIB NIH HHS U18 EB021716NIDA NIH HHS T32 DA007234NINDS NIH HHS R34 NS111654
6 · The paper itself

Abstract

Adeno-associated viral (AAV) vectors allow for site-specific and time-dependent genetic manipulation of neurons. However, for successful implementation of AAV vectors, major consideration must be given to the selection of viral serotype and route of delivery for efficient gene transfer into the cell type being investigated. Here we compare the transduction pattern of neurons in the somatosensory system following injection of AAV9 or AAV2retro in the parabrachial complex of the midbrain, the spinal cord dorsal horn, the intrathecal space, and the colon. Transduction was evaluated based on Cre-dependent expression of tdTomato in transgenic reporter mice, following delivery of AAV9 or AAV2retro carrying identical constructs that drive the expression of Cre/GFP. The pattern of distribution of tdTomato expression indicated notable differences in the access of the two AAV serotypes to primary afferent neurons via peripheral delivery in the colon and to spinal projections neurons via intracranial delivery within the parabrachial complex. Additionally, our results highlight the superior sensitivity of detection of neuronal transduction based on reporter expression relative to expression of viral products.

Indexed as

DependovirusGenetic VectorsAnimalsGenetic TherapyGene Transfer TechniquesMiceMice, TransgenicNeuronsTransduction, Genetic

Identifiers

PMID35271639
PMCPMC8912232
OpenAlexW4220824022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.